Conference Coverage

What’s next for Watchman stroke prevention device


 

EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS

References

If such a combined procedure can be done efficiently, it should enable recipients of AF catheter ablation to safely go off oral anticoagulation, noted Dr. Asirvatham, an electrophysiologist who is professor of medicine and pediatrics at the Mayo Clinic, Rochester, Minn.

Dr. Holmes said several small studies of patients who have received combined AF ablation and Watchman implantation have been published.

“It’s uncertain whether left atrial appendage closure will affect AF recurrence rates post ablation, but it should reduce stroke risk. It’s a terribly important field of exploration that will be pursued in registries both in Europe and the United States,” he said.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Experts call for international cooperation on human gene editing
MDedge Neurology
AHA: Ezetimibe reduces ischemic stroke risk
MDedge Neurology
Study characterizes intracerebral hemorrhage with new oral anticoagulants
MDedge Neurology
Cold weather linked to increase in strokes, MI
MDedge Neurology
Statins might prevent vascular inflammation in sleep apnea
MDedge Neurology
EADV: Family history of cardiovascular disease is key in psoriasis patients
MDedge Neurology
AHA: Poor real-world adherence to NOACs
MDedge Neurology
Experts say abandon aspirin for stroke prevention in atrial fib
MDedge Neurology
Therapeutic hypothermia called biggest recent advance in cardiac arrest
MDedge Neurology
New ROCKET-AF review claims faulty INR monitoring device didn’t affect results
MDedge Neurology